ATNM vs. ENTX
ATNM (Actinium Pharmaceuticals, Inc.) and ENTX (Entera Bio Ltd) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, ATNM returned -33.49%/yr vs -23.99%/yr for ENTX. At a 0.15 correlation, their price movements are largely independent.
Performance
ATNM vs. ENTX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ATNM achieves a -25.00% return, which is significantly lower than ENTX's -20.10% return.
ATNM
- 1D
- -0.97%
- 1M
- -13.56%
- YTD
- -25.00%
- 6M
- -35.44%
- 1Y
- -32.89%
- 3Y*
- -48.60%
- 5Y*
- -33.49%
- 10Y*
- -32.45%
ENTX
- 1D
- 4.73%
- 1M
- 25.00%
- YTD
- -20.10%
- 6M
- -11.93%
- 1Y
- -20.92%
- 3Y*
- 23.26%
- 5Y*
- -23.99%
- 10Y*
- —
ATNM vs. ENTX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
ATNM Actinium Pharmaceuticals, Inc. | -25.00% | 7.94% | -75.20% | -52.30% | 77.20% | -22.95% | 19.27% | -43.67% | -37.88% |
ENTX Entera Bio Ltd | -20.10% | -8.49% | 253.33% | -17.81% | -74.07% | 160.65% | -49.53% | -29.84% | -58.22% |
Correlation
The correlation between ATNM and ENTX is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.06 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.14 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.18 |
Correlation (All Time) Calculated using the full available price history since Jun 28, 2018 | 0.15 |
The correlation between ATNM and ENTX shifts across timeframes, from 0.06 (1 year) to 0.18 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
ATNM:
$31.86M
ENTX:
$74.02M
ATNM:
-$0.75
ENTX:
-$0.11
ATNM:
13.83
ENTX:
6.93
ATNM:
$90.00K
ENTX:
$0.00
ATNM:
$485.00K
ENTX:
-$15.00K
ATNM:
-$24.68M
ENTX:
-$12.42M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ATNM vs. ENTX — Risk / Return Rank
ATNM
ENTX
ATNM vs. ENTX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Actinium Pharmaceuticals, Inc. (ATNM) and Entera Bio Ltd (ENTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ATNM | ENTX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.26 | ||
| Sortino ratioReturn per unit of downside risk | -0.72 | ||
| Omega ratioGain probability vs. loss probability | 0.95 | 1.03 | -0.07 |
| Calmar ratioReturn relative to maximum drawdown | -0.69 | -0.31 | -0.39 |
| Martin ratioReturn relative to average drawdown | -1.15 | -0.50 | -0.65 |
Loading charts...
Drawdowns
ATNM vs. ENTX - Drawdown Comparison
The maximum ATNM drawdown since its inception was -99.75%, which is greater than ENTX's maximum drawdown of -93.15%. Use the drawdown chart below to compare losses from any high point for ATNM and ENTX.
Loading charts...
Drawdown Indicators
| ATNM | ENTX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.75% | -93.15% | -6.60% |
Max Drawdown (1Y)Largest decline over 1 year | -47.59% | -68.15% | +20.56% |
Max Drawdown (3Y)Largest decline over 3 years | -90.09% | -68.15% | -21.94% |
Max Drawdown (5Y)Largest decline over 5 years | -93.20% | -92.05% | -1.15% |
Max Drawdown (10Y)Largest decline over 10 years | -98.37% | — | — |
Current DrawdownCurrent decline from peak | -99.74% | -78.77% | -20.97% |
Average DrawdownAverage peak-to-trough decline | -85.42% | -68.15% | -17.27% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 28.75% | 42.00% | -13.25% |
Volatility
ATNM vs. ENTX - Volatility Comparison
The current volatility for Actinium Pharmaceuticals, Inc. (ATNM) is 16.73%, while Entera Bio Ltd (ENTX) has a volatility of 26.30%. This indicates that ATNM experiences smaller price fluctuations and is considered to be less risky than ENTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ATNM | ENTX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.73% | 26.30% | -9.57% |
Volatility (6M)Calculated over the trailing 6-month period | 44.99% | 72.34% | -27.35% |
Volatility (1Y)Calculated over the trailing 1-year period | 65.44% | 87.26% | -21.82% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 79.87% | 87.15% | -7.28% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 81.43% | 110.26% | -28.83% |
Dividends
ATNM vs. ENTX - Dividend Comparison
Neither ATNM nor ENTX has paid dividends to shareholders.
Financials
ATNM vs. ENTX - Financials Comparison
This section allows you to compare key financial metrics between Actinium Pharmaceuticals, Inc. and Entera Bio Ltd. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ATNM and ENTX have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ENTX has higher volatility (26.30%) compared to ATNM (16.73%). In terms of maximum drawdown, ATNM dropped -99.75% vs ENTX's -93.15%.
ENTX currently has the higher Sharpe Ratio (-0.24 vs -0.50), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ATNM and ENTX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer